South Korea’s Trade, Industry and Energy Minister Kim Jung-kwan said Seoul will monitor the impact of the US midterm elections and respond flexibly to changes in US policy and Congress. He said AI investment is likely to continue expanding structurally, is unlikely to be derailed by short-term volatility, and that current conditions present a favorable time to invest; Seoul will avoid overreacting to near-term developments.

The Shanghai Municipal Food and Drug Safety Commission issued a 15th Five-Year Plan to ensure drug safety and promote high-quality pharmaceutical development, outlining multiple regulatory reforms. It will deepen clinical-trial review and approval reforms for innovative drugs and support R&D. The plan calls for reforming review and approval procedures for supplemental applications for domestic and overseas chemical drug production and offering front-end support for major change filings on local chemical drugs. Shanghai will seek pilot programs for dossier-based review of generics to accelerate first-to-market generics, streamline post-approval change processes, pilot continuous manufacturing technologies, and optimize temporary import procedures for clinically urgent medicines.

香港交易所信息显示，贝莱德在长飞光纤光缆H股的持股比例于11月4日从6.84%升至8.93%。